🔎 Trials Near Me

Home › Open-Angle Glaucoma › Pennsylvania

Pag-aaral pangklinika para sa Open-Angle Glaucoma sa Pennsylvania

6 pag-aaral para sa Open-Angle Glaucoma ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

  • Ophthalmic Partners of PA /ID# 276059, Bala-Cynwyd
  • Wills Eye Hospital /ID# 268569, Philadelphia
Nagre-recruitPhase 3
Edad 45 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06822738

Hydrus® Microstent New Enrollment Post-Approval Study

  • Scott & Christie and Associates, PC, Cranberry Township
Nagre-recruit
Edad 45 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04553523

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

  • Wills Eye Glaucoma Service, Philadelphia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT03675412

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

  • Scheie Eye Institute, Philadelphia
  • Wills Eye Hospital, Philadelphia
Nagre-recruit
Edad 45 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT07220876

Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

  • Wills Eye Hosital Glaucoma Dept., Philadelphia
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT07228221

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

  • Shafer Vision Institute, Plymouth Meeting
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2025 · NCT07076303

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.